Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Boxer Capital
269
Boxer Capital
Tavistock Group is an international private investment organization founded by Joe Lewis more than 40 years ago and built on a core philosophy: We strive for excellence in everything we do.
Suggest edits
Follow us
Overview
News
Investments
17
Portfolio
Portfolio Tracker
Add info
$85,000,000
Venture capital (Series C)
FinSMEs
,
GeekWire
Silverback Therapeutics Raises $85M in Series C Financing
ChinaMoneyNetwork
Connect Biopharmaceuticals Raises $115M Series C Round – China Money Network
ChinaMoneyNetwork
Connect Biopharmaceuticals Raises $115M Series C Round – China Money Network
$115,000,000
Venture capital (Series C)
Pulse 2.0
,
FinSMEs
Clinical-Stage Biopharmaceutical Company Connect Biopharma Raises $115 Million
Pulse 2.0
Targeted Cancer Therapy Biotech Company Tango Therapeutics Raises $50 Million
Xconomy
Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor
$50,000,000
Venture capital
FinSMEs
Tango Therapeutics Raises $50M in Equity Financing
$135,000,000
Venture capital (Series D)
FinSMEs
,
Pulse 2.0
Encoded Therapeutics Raises $135M in Series D Financing
$72,500,000
Venture capital (Series D)
FinSMEs
BioAtla Raises $72.5M In Series D Financing
neurons.AI
Global Superoxide Dismutase Cu-Zn Market 2020 – AveXis Inc , Ionis Pharmaceuticals Inc …
$110,000,000
Venture capital (Series D)
FinSMEs
Poseida Therapeutics Raises $110M in Series D Financing
$60,000,000
Venture capital (Series B)
Pulse 2.0
Targeted Cancer Therapies Company Tango Closes $60 Million
Xconomy
Silverback Therapeutics Adds $79M to Test HER2+ Tumor-Targeting Drug
FinSMEs
Silverback Therapeutics Raises $78.5M in Series B Financing
$50,000,000
Venture capital (Series A)
FinSMEs
Tyra Biosciences Raises USD 50M in Series A Funding
the home of AI info
Global Superoxide Dismutase [Cu-Zn] Market 2016-2026 | AveXis Inc, Ionis Pharmaceuticals Inc ...
Technical.ly Philly
University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO
PE HUB
VC-backed Cabaletta Bio begins trading on NASDAQ
$113,800,000
IPO
PE HUB
Biopharma firm Atreca goes public
$50,000,000
Venture capital (Series B)
MedCity News
,
FinSMEs
Cabaletta Bio closes $50M Series B round for cell-based autoimmune disease therapies
